Lantheus Holdings to Acquire Evergreen Theragnostics in Definitive Agreement
Lantheus Holdings, Inc., the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced a definitive agreement to acquire Evergreen Theragnostics, Inc. (“Evergreen”), in an all-cash transaction consisting of an upfront pa…
